Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An algorithm for model construction and its applications to pharmacogenomic studies.

Kung-Hao Liang1, Yuchi Hwang2, Wan-Ching Shao3

  • 1Vita Genomics, Inc., 7F, No. 6, Sec. 1, Jungshing Rd., Wugu Shiang, Taipei, 248, Taiwan. kunghao.liang@vitagenomics.com.

Journal of Human Genetics
|August 11, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Deep Learning Prognostic Model for Diabetes Patients Using Bilateral Fundus Imaging.

Journal of diabetes science and technology·2026
Same author

Population-specific polygenic risk scores for people of Han Chinese ancestry.

Nature·2025
Same author

Deep neural network-based detection of lead contamination via Förster resonance energy transfer in live cells.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

Discovery of TBK1-Associated Oncogenic Mechanisms in Patients With Upper Tract Urothelial Carcinoma and Pre-Existing End-Stage Renal Disease.

Clinical genitourinary cancer·2025
Same author

Multimodal single-cell transcriptomics with patient-specific iPSC-derived airway organoids as a drug screening approach for cystic fibrosis with nonsense mutations.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Predictive biosignatures for hospitalization in patients with virologically confirmed COVID-19.

Journal of the Chinese Medical Association : JCMA·2024

This study introduces a new algorithm using genetic algorithms and Boolean algebra (GABA) to build predictive pharmacogenomic models from multiple single-nucleotide polymorphisms (SNPs). The method effectively predicts treatment efficacy for complex diseases like chronic hepatitis C.

Area of Science:

  • Genetics
  • Pharmacogenomics
  • Computational Biology

Background:

  • Predicting clinical phenotypes and treatment responses from genotypes is crucial for personalized medicine.
  • Single-locus polymorphisms often lack sufficient information for accurate patient stratification due to complex biological interactions.
  • Exhaustive genotype combination searches are computationally intractable.

Purpose of the Study:

  • To develop a novel algorithm for constructing pharmacogenomic models using multiple single-nucleotide polymorphism (SNP) data.
  • To address the computational challenges in identifying relevant genotype combinations for predictive modeling.
  • To create a model for predicting treatment efficacy in chronic hepatitis C patients.

Main Methods:

  • Developed a novel algorithm integrating genetic algorithms and Boolean algebra (GABA).

Related Experiment Videos

  • Utilized multiple single-nucleotide polymorphism (SNP) information in diplotype forms.
  • Tested the algorithm on simulated data and real genotype datasets from chronic hepatitis C patients.

    • Main Results:

    • The proposed GABA algorithm successfully constructed and validated a predictive model for treatment efficacy.
    • The algorithm demonstrated high effectiveness in deriving models incorporating multiple SNPs.
    • The model accurately predicted treatment outcomes for chronic hepatitis C patients receiving interferon-combined therapy.

    Conclusions:

    • The novel GABA algorithm provides an effective computational approach for building complex pharmacogenomic models.
    • This method enhances the ability to stratify patients and predict treatment efficacy using multi-SNP data.
    • The findings have significant implications for personalized medicine and drug development.